108 related articles for article (PubMed ID: 24647772)
21. Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line.
Roy KR; Reddy GV; Maitreyi L; Agarwal S; Achari C; Vali S; Reddanna P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):903-11. PubMed ID: 19685055
[TBL] [Abstract][Full Text] [Related]
22. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells.
Han J; Zhang F; Yu M; Zhao P; Ji W; Zhang H; Wu B; Wang Y; Niu R
Cancer Lett; 2012 Aug; 321(1):80-8. PubMed ID: 22381696
[TBL] [Abstract][Full Text] [Related]
23. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
[TBL] [Abstract][Full Text] [Related]
24. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
Nishanth RP; Ramakrishna BS; Jyotsna RG; Roy KR; Reddy GV; Reddy PK; Reddanna P
Eur J Pharmacol; 2010 Dec; 649(1-3):74-83. PubMed ID: 20858479
[TBL] [Abstract][Full Text] [Related]
25. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
[TBL] [Abstract][Full Text] [Related]
26. Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1.
Hassan S; Peluso J; Chalhoub S; Idoux Gillet Y; Benkirane-Jessel N; Rochel N; Fuhrmann G; Ubeaud-Sequier G
PLoS One; 2020; 15(10):e0240676. PubMed ID: 33052979
[TBL] [Abstract][Full Text] [Related]
27. Stem cell transcription factor NANOG in cancers--is eternal youth a curse?
Wong OG; Cheung AN
Expert Opin Ther Targets; 2016; 20(4):407-17. PubMed ID: 26634876
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of hepatic lipase is associated with decreased CD133 expression and clone formation in HepG2 cells.
Liu X; Zuo J; Fang Y; Wen J; Deng F; Zhong H; Jiang B; Wang J; Nie B
Int J Mol Med; 2018 Oct; 42(4):2137-2144. PubMed ID: 30015857
[TBL] [Abstract][Full Text] [Related]
29. Slug promotes hepatocellular cancer cell progression by increasing sox2 and nanog expression.
Zhao X; Sun B; Sun D; Liu T; Che N; Gu Q; Dong X; Li R; Liu Y; Li J
Oncol Rep; 2015 Jan; 33(1):149-56. PubMed ID: 25339068
[TBL] [Abstract][Full Text] [Related]
30. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.
Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO
Cell Stem Cell; 2011 Jul; 9(1):50-63. PubMed ID: 21726833
[TBL] [Abstract][Full Text] [Related]
31. Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil.
Khosravi N; Shahgoli VK; Amini M; Safaei S; Mokhtarzadeh A; Mansoori B; Derakhshani A; Baghbanzadeh A; Baradaran B
Eur J Pharmacol; 2021 Mar; 894():173871. PubMed ID: 33460610
[TBL] [Abstract][Full Text] [Related]
32. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
[TBL] [Abstract][Full Text] [Related]
33. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells.
Yu ST; Chen TM; Tseng SY; Chen YH
Biochem Biophys Res Commun; 2007 Jun; 358(1):79-84. PubMed ID: 17482571
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein.
Wu F; Shao ZY; Zhai BJ; Zhao CL; Shen DM
Ultrasound Med Biol; 2011 Jan; 37(1):151-9. PubMed ID: 21084157
[TBL] [Abstract][Full Text] [Related]
35. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
36. Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.
Ni W; Chen B; Zhou G; Lu C; Xiao M; Guan C; Zhang Y; He S; Shen A; Ni R
J Cell Biochem; 2013 Sep; 114(9):2120-30. PubMed ID: 23553841
[TBL] [Abstract][Full Text] [Related]
37. Regulation of NANOG in cancer cells.
Gong S; Li Q; Jeter CR; Fan Q; Tang DG; Liu B
Mol Carcinog; 2015 Sep; 54(9):679-87. PubMed ID: 26013997
[TBL] [Abstract][Full Text] [Related]
38. Overcoming multi-drug resistance by anti-MDR1 ribozyme.
Wang H; Chen XP; Qiu FZ
World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
[TBL] [Abstract][Full Text] [Related]
40. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
Gandhy SU; Imanirad P; Jin UH; Nair V; Hedrick E; Cheng Y; Corton JC; Kim K; Safe S
Oncotarget; 2015 Sep; 6(28):26359-72. PubMed ID: 26317792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]